Speakers
David Apelian , CEO , Theolytics
Maina Bhaman , Partner , Sofinnova Partners
Roel Bulthuis , Managing Partner , Syncona
Mary Clark , CEO , Optimum Strategic Communications
Lucy Edwardes Jones , Life Sciences Investor , BGF
Chris Floyd , Head of Neuroscience , TranScrip
Ashleigh Furlong , Health Reporter , Bloomberg
Hakan Goker , Managing Director , M Ventures
Stephen Hansen , Director of Biopharma Intelligence , BioCentury
Olav Hellebø , Chairman , Blue Cell Therapeutics
Adi Hoess , CEO , ViaNautis Bio
Marguerite Hutchinson , Chief Business Officer , STORM Therapeutics
Orr Inbar , Co-Founder and CEO , QuantHealth
Mattias Johansson , CEO , Ezenze Ltd
Harel Kotler , Clinical AI Lead , Merck Healthcare
Charlotte Kremers , Principal , M Ventures
Colette Lipp , Senior Director, Global Oncology and Immuno-Oncology Licensing and Business Development , Merck KGaA
Allan Marchington , Managing Director & Head of Life Sciences , ICG
Dr Laura Matz , Chief Science and Technology , Merck KGaA
Tara Raveendran , Head of Healthcare Research , Polar Capital
Nicki Thompson , CEO , TRIMTECH Therapeutics
Mike Ward , Global Head of Life Sciences & Healthcare Thought Leadership , Clarivate
